Looking to publish in Gastric Cancer? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowGastric Cancer is a high-level global forum dedicated to all areas of research, treatment, and biology relevant to gastric cancer. It welcomes original articles, case reports, short communications, technical notes, and Letters to the Editor, while review articles are primarily solicited by the Editor.
Looking to publish in Gastric Cancer? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Gastric Cancer accepts the following article types. Click on an article type to view submission instructions.
Original Articles
Review Articles
Meta-Analysis Studies
Case Reports
Short Communications
Letters To The Editor
Recent Publications
Clinical advantages of robotic gastrectomy for gastric cancer over conventional laparoscopic approach: a retrospective cohort study using a nationwide registry database in Japan
Susumu Shibasaki, Hideki Endo, Hiroyuki Yamamoto, Masaya Nakauchi, Tsuyoshi Tanaka, Shigeo Hisamori, Kazutaka Obama, Hirokazu Noshiro, Koshi Kumagai, Hideki Ueno, Ken Shirabe, Ichiro Uyama, Koichi Suda
Hospital-based gastric cancer outcomes in the United States (2003–2022): racial and regional disparities
Yasutoshi Shiratori, Neha Sharma, Syed Matthew Kodilinye, Carla Barberan Parraga, Fatima Khan, Ahmed E. Salem, Sarah Meribout, Diana Cheung, Aaron Tokayer, Anthony Kalloo, Linda A. Lee
Feasibility study of cap-assisted endoscopic mucosal resection for gastric adenocarcinoma of fundic gland type
Risa Ashizaki, Tetsuya Yoshizaki, Yuta Higasa, Hiroshi Tanabe, Eri Nishikawa, Shinya Hoki, Ryosuke Ishida, Hitomi Hori, Tatsuya Nakai, Chise Ueda, Satoshi Urakami, Hirofumi Abe, Madoka Takao, Toshitatsu Takao, Masakyo Asahara, Yoshinori Morita, Takashi Toyonaga, Yuzo Kodama
Circulating tumor DNA-guided response evaluation in patients with previously treated gastroesophageal adenocarcinoma
Cecilie Riis Iden, Nadia Øgaard, Salah Mohammad Mustafa, Ida Coordt Elle, Mette Yilmaz, Marianne Nordsmark, Tenna Henriksen, Torben Kruse, Mads Thomassen, Per Pfeiffer, Claus Lindbjerg Andersen, Lene Bæksgaard, Camilla Qvortrup, Morten Mau-Sørensen
Prognostic implications of tissue-based homologous recombination deficiency in metastatic gastric cancer treated with immune checkpoint inhibitor plus chemotherapy
Changgon Kim, Junkyu Kim, Ji Eun Shin, Sung Hee Lim, Kyoung-Mee Kim, Deok Geun Kim, Jeeyun Lee, Seung Tae Kim
Frequently asked questions
How long does it take to publish?
Prospective randomized controlled trials must be registered within 6 months from first patient enrollment. Articles are published online after receipt of corrected proofs.
Reformat to Gastric Cancer using Livewrite PremiumIs a cover letter required?
A submission letter is referenced for reviewer suggestions and for transparency on reuse of material and unpublished material included in the manuscript.
Reformat to Gastric Cancer using Livewrite PremiumWhat are the publication costs?
Open access APC: £3690.00 GBP / $5690.00 USD / €4390.00 EUR. Subscription publishing has no APC charges.
Reformat to Gastric Cancer using Livewrite Premium